Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I and Pharmacodynamic Study of SB-715992 [ispinesib] in Acute Leukemias.

Trial Profile

Phase I and Pharmacodynamic Study of SB-715992 [ispinesib] in Acute Leukemias.

Phase of Trial: Phase I

Latest Information Update: 10 Jan 2013

At a glance

  • Drugs Ispinesib (Primary)
  • Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 11 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Sep 2011 Planned end date changed from 1 Feb 2008 to 1 May 2008 as reported by ClinicalTrials.gov.
    • 16 Mar 2010 Actual number of patients (36) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top